Workflow
金城医药:子公司收到化学原料药上市批准通知书

Core Viewpoint - Jincheng Pharmaceutical's subsidiary, Beijing Jincheng Tail Pharmaceutical Co., Ltd., has received approval from the National Medical Products Administration for the marketing application of the chemical raw material drug, Erythromycin Lactobionate [2] Group 1 - The approved chemical raw material drug is Erythromycin Lactobionate [2]